[1]
N. Ghaffar and K. Tahir, “The Limits of a Reporting Baseline: Sex Differences in Adverse Event Reporting for Tumour Necrosis Factor Blockers, GLP-1 Receptor Agonists and Proton Pump Inhibitors Across 1,753,642 Reports”, Electron. J. Med. Res., vol. 2, no. 2, pp. 54–60, May 2026, doi: 10.64813/ejmr.2026.089.